# Outpatient Use of Ivermectin in COVID-19

> **NCT04530474** · PHASE3 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04530474
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** WHO report
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530474, "Outpatient Use of Ivermectin in COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04530474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*